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Background: Melioidosis is an emerging infectious disease
caused by soil inhabitant gram negative bacterium Burkholderia
pseudomallei. The diseasewhich is endemic in Thailand andNorth-
ern Australia has shown an increasing trend in India in past few
years. Epidemiological study of clinical isolates and their genetic
relatedness to strains from neighboring south Asian countries
remainsundeﬁned. Theaimof the studywas to analyze themolecu-
lar diversity of clinical B.pseudomallei isolates from southern India.
Methods & Materials: A total of 28 clinical strains of
B.pseudomallei isolated from patients diagnosed with melioido-
sis at a tertiary care teaching hospital in southern India were
included in the study. All isolated were subjected to Multilocus
sequence typing (MLST) by ampliﬁcation and sequencing of seven
housekeeping genes. Sequences obtained from each locus were
compared with the mlst database available on http://mlst.net. Fur-
ther, sequence types (ST)were assigned for each isolatewere tested
for their genetic relatedness using e-burst analysis to the STs of
isolates reported from neighboring countries of south Asia.
Results: Of the 28 isolates tested, 26 isolates had novel allelic
proﬁles and2 isolatesmatchedwithpreviously reportedallelic pro-
ﬁles. Among the 26 isolates with novel allelic proﬁles, 15(53.6%)
isolates were assigned as a new ST 1368 and the other 10 (38.4%)
isolates were assigned STs 1369, 1370 (2), 1371(2), 1372, 1375(2),
1379 and 1380. One isolate had a novel allele in the gltB region.
Two isolates which matched in their STs with previously reported
isolates on theMLST database belonged to a single patientwhopre-
sented initially with a systemic illness followed by a localized form
of re-infection. Upon eburst analysis, we observed distinct molec-
ular epidemiology of our isolates in comparison with STs reported
from the neighboring countries of south Asia.
Conclusion: Predominance of a novel ST 1368 among our
patients, which does not demonstrate genetic relatedness with
other STs from neighboring countries of South Asia as well as from
Australia was observed in the study. Further, our study ﬁndings
underscore the high level of genetic diversity among clinical iso-
lates of B. pseudomallei from coastal parts of south western India.
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Background: HLA class II is a highly polymorphic cell surface
glycoprotein, crucial for regulating host immune responses and
thereby determining the disease outcome in visceral leishmaniasis
by their ability to present the foreign antigens to CD4+ T lympho-
cytes andactivating theT-cells. The complex regulationofHLAclass
II in different cellular compartments through class II transactivator
gene (CIITA)determines the triggeringandmaintenanceof immune
responses and has vital role in determining the parasite clearance.
The complex transcriptional regulation by CIITA is mediated upon
its nuclear import by IFN- and hence regulating the expression
of HLA-DR. This study tries to provide answer to the complex reg-
ulation of HLA-DR mediated via. CIITA at the gene as well as the
functional level in visceral leishmaniasis cases.
Methods & Materials: The study was performed on whole
blood/PBMC and splenic aspirates from VL cases pre-/post-
treatment and endemic control groups whole blood/PBMC.
Gene(mRNA) expression was performed with the peripheral blood
mononuclear cells(PBMC)and the splenic aspirates while the sur-
face(protein) expression was performed with the whole blood and
splenic aspirates from cases pre-/post-treatment.
Results: There was signiﬁcantly lower expression of DRB1
(p=0.047) in active cases compared to healthy controls but there
were no signiﬁcant differences in DRB1 expression in active cases
compared topairedcuredcases ineitherPBMC(p=0.848)or splenic
aspirates (p =0.628) while CIITA expression was higher at post-
treatment as compared to pre-treated cases in splenic aspirates as
well as the PBMC. At the cellular level, HLA-DR was signiﬁcantly
increased on CD14, CD16 and CD19 positive populations while
CD4+ cells were having lowered kinetics of expression upon drug
cure in splenic as well as the whole blood.
Conclusion:We found that theHLA-DR expression by cell types
was similar in splenic aspirates as well as the whole blood assays
but there were functional differences in the levels of HLA-DR
expression at the gene aswell as the protein level. The variable lev-
els of expression of HLA-DR on macrophages and B-cells indicates
for targeting these cell populations for modulating the immune
responses by altering the antigen processing and presentation abil-
ities hence designing the therapeutic/prophylactic options for VL.
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